Prevalencia del cáncer de próstata en la comuna de Talca, VII región Chile

Background: In 1998, there were 1,218 deaths in Chile caused by prostate cancer. This figure results in a death rate of 16.6 per 100,000 males for this disease. Aim: To assess the prevalence of prostate cancer in the Seventh Region of Chile. Material and methods: A probabilistic sample of 327 males...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Baechler R,Roberto, Henríquez D,René, Aqueveque S,Ximena, Martínez P,María E., Soto P,Alex
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2001
Materias:	Carcinoma in situ, Prostate - specific antigen Prostatic neoplasms
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001001100010
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872001001100010
record_format	dspace
spelling	oai:scielo:S0034-988720010011000102002-06-12Prevalencia del cáncer de próstata en la comuna de Talca, VII región ChileBaechler R,RobertoHenríquez D,RenéAqueveque S,XimenaMartínez P,María E.Soto P,Alex Carcinoma in situ, Prostate - specific antigen Prostatic neoplasms Background: In 1998, there were 1,218 deaths in Chile caused by prostate cancer. This figure results in a death rate of 16.6 per 100,000 males for this disease. Aim: To assess the prevalence of prostate cancer in the Seventh Region of Chile. Material and methods: A probabilistic sample of 327 males aged 40 to 59 years old was studied. In all, a codified questionnaire was applied, a digital rectal examination was performed and a blood sample was drawn to measure prostate specific antigen. All digital rectal examinations were performed by the same observer. Patients with an abnormal rectal examination or prostate specific antigen were subjected to a prostatic biopsy under ultrasound guidance. Results: In 14 subjects, the digital rectal examination was considered abnormal and in seven, prostate specific antigen was over 4 ng/ml. All subjects with elevated prostate specific antigen had an abnormal rectal examination. In three of the 14 subjects, the biopsy showed a well differentiated adenocarcinoma. All three were aged over 50 years old. The resulting calculated prevalence of prostate cancer was 9.2 per 1,000 males (CI 4.2-14.1). Conclusions: the cost effectiveness of screening for early diagnosis of prostate cancer must be calculated, to decide its incorporation in preventive medical examinations (Rev Méd Chile 2001; 129: 1305-10)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.129 n.11 20012001-11-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001001100010es10.4067/S0034-98872001001100010
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Carcinoma in situ, Prostate - specific antigen Prostatic neoplasms
spellingShingle	Carcinoma in situ, Prostate - specific antigen Prostatic neoplasms Baechler R,Roberto Henríquez D,René Aqueveque S,Ximena Martínez P,María E. Soto P,Alex Prevalencia del cáncer de próstata en la comuna de Talca, VII región Chile
description	Background: In 1998, there were 1,218 deaths in Chile caused by prostate cancer. This figure results in a death rate of 16.6 per 100,000 males for this disease. Aim: To assess the prevalence of prostate cancer in the Seventh Region of Chile. Material and methods: A probabilistic sample of 327 males aged 40 to 59 years old was studied. In all, a codified questionnaire was applied, a digital rectal examination was performed and a blood sample was drawn to measure prostate specific antigen. All digital rectal examinations were performed by the same observer. Patients with an abnormal rectal examination or prostate specific antigen were subjected to a prostatic biopsy under ultrasound guidance. Results: In 14 subjects, the digital rectal examination was considered abnormal and in seven, prostate specific antigen was over 4 ng/ml. All subjects with elevated prostate specific antigen had an abnormal rectal examination. In three of the 14 subjects, the biopsy showed a well differentiated adenocarcinoma. All three were aged over 50 years old. The resulting calculated prevalence of prostate cancer was 9.2 per 1,000 males (CI 4.2-14.1). Conclusions: the cost effectiveness of screening for early diagnosis of prostate cancer must be calculated, to decide its incorporation in preventive medical examinations (Rev Méd Chile 2001; 129: 1305-10)
author	Baechler R,Roberto Henríquez D,René Aqueveque S,Ximena Martínez P,María E. Soto P,Alex
author_facet	Baechler R,Roberto Henríquez D,René Aqueveque S,Ximena Martínez P,María E. Soto P,Alex
author_sort	Baechler R,Roberto
title	Prevalencia del cáncer de próstata en la comuna de Talca, VII región Chile
title_short	Prevalencia del cáncer de próstata en la comuna de Talca, VII región Chile
title_full	Prevalencia del cáncer de próstata en la comuna de Talca, VII región Chile
title_fullStr	Prevalencia del cáncer de próstata en la comuna de Talca, VII región Chile
title_full_unstemmed	Prevalencia del cáncer de próstata en la comuna de Talca, VII región Chile
title_sort	prevalencia del cáncer de próstata en la comuna de talca, vii región chile
publisher	Sociedad Médica de Santiago
publishDate	2001
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001001100010
work_keys_str_mv	AT baechlerrroberto prevalenciadelcancerdeprostataenlacomunadetalcaviiregionchile AT henriquezdrene prevalenciadelcancerdeprostataenlacomunadetalcaviiregionchile AT aquevequesximena prevalenciadelcancerdeprostataenlacomunadetalcaviiregionchile AT martinezpmariae prevalenciadelcancerdeprostataenlacomunadetalcaviiregionchile AT sotopalex prevalenciadelcancerdeprostataenlacomunadetalcaviiregionchile
_version_	1718436000996261888

Prevalencia del cáncer de próstata en la comuna de Talca, VII región Chile

Ejemplares similares